1
|
Chen L, Zhang X, Liu Y, Liu L, Liang X, Yang S, Xia Q, Jin T, Ma Y, Chen Y, Yuan X, Tie Y, Gu Y, Fang C, Chen S, Mo F, Yu T, Hu Y, Qian Z, Peng Y, Geng J, Zhou Z, Wu M, Ding J, Yang D, Wei X. JMJD3 Is Required for Acute Pancreatitis and Pancreatitis-Associated Lung Injury. JOURNAL OF IMMUNOLOGY (BALTIMORE, MD. : 1950) 2023; 210:180-190. [PMID: 36458991 PMCID: PMC9772398 DOI: 10.4049/jimmunol.2200484] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/08/2022] [Accepted: 11/01/2022] [Indexed: 01/04/2023]
Abstract
Acute pancreatitis (AP) can be complicated by inflammatory disorders of remote organs, such as lung injury, in which Jumonji domain-containing protein 3 (JMJD3) plays a vital role in proinflammatory responses. Currently, we found that JMJD3 expression was upregulated in the pancreas and lung in an AP male mouse model, which was also confirmed in AP patients. Further experiments revealed that the upregulation of JMJD3 and proinflammatory effects were possibly exerted by mitochondrial DNA (mtDNA) or oxidized-mtDNA from tissue injury caused by AP. The release of mtDNA and oxidized-mtDNA contributed to the infiltration of inflammatory monocytes in lung injury through the stimulator of IFN genes (STING)/TLR9-NF-κB-JMJD3-TNF-α pathway. The inhibition of JMJD3 or utilization of Jmjd3-cKO mice significantly alleviated pulmonary inflammation induced by AP. Blocking mtDNA oxidation or knocking down the TLR9/STING pathway effectively alleviated inflammation. Therefore, inhibition of JMJD3 or STING/TLR9 pathway blockage might be a potential therapeutic strategy to treat AP and the associated lung injury.
Collapse
Affiliation(s)
- Li Chen
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Xiangxian Zhang
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Yu Liu
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Li Liu
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Xiao Liang
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Shengqun Yang
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Qing Xia
- Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Tao Jin
- Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Yun Ma
- Department of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Yonghua Chen
- Department of Pancreatic Surgery/Pancreatic Disease Center, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Xia Yuan
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Yan Tie
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Yangzhuo Gu
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Chunju Fang
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Siyuan Chen
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Fei Mo
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Ting Yu
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Yuzhu Hu
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Zhiyong Qian
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Yong Peng
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Jia Geng
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Zongguang Zhou
- Department of Gastrointestinal Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| | - Min Wu
- Department of Biochemistry and Molecular Biology, School of Medicine and Health Sciences, University of North Dakota, Grand Forks, ND; and
| | - Jiansheng Ding
- Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Daoke Yang
- Department of Radiotherapy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Xiawei Wei
- Laboratory of Aging Research and Nanotoxicology, State Key Laboratory of Biotherapy, West China Hospital, National Clinical Research Center for Geriatrics, West China Hospital, Sichuan University, Chengdu, Sichuan, People’s Republic of China
| |
Collapse
|